New patent for Gilead Sciences drug VITEKTA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for VITEKTA
Annual Drug Patent Expirations for VITEKTA

Vitekta is a drug marketed by Gilead Sciences Inc and is included in one NDA. There are three patents protecting this drug.

Drug patent litigation for VITEKTA.

This drug has seventy-three patent family members in thirty-four countries.

The generic ingredient in VITEKTA is elvitegravir. Additional details are available on the elvitegravir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top